We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients.
- Authors
Valantin, M. A.; Bittar, R.; de Truchis, P.; Bollens, D.; Slama, L.; Giral, P.; Bonnefont-Rousselot, D.; Pétour, P.; Aubron-Olivier, C.; Costagliola, D.; Katlama, C.
- Abstract
Objectives: To assess the impact of switching to tenofovir disoproxil fumarate + emtricitabine on lipid parameters.
- Subjects
NUCLEOSIDES; SUCCINATE dehydrogenase; REVERSE transcriptase; TRIGLYCERIDES; LOW density lipoproteins; CHOLESTEROL
- Publication
Journal of Antimicrobial Chemotherapy (JAC), 2010, Vol 65, Issue 3, p556
- ISSN
0305-7453
- Publication type
Article
- DOI
10.1093/jac/dkp462